Viral and Genetic Regulation of Abnormal OCL Activity in PD
Viral and Genetic Regulation of Abnormal OCL Activity in PD
批准号:
8315745
负责人:
DEBORAH Lynn GALSON
金额:
$31.54万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-16 至 2014-08-31
关键词:
Animal ModelCCAAT-Enhancer-Binding ProteinsCREB1 geneCalcineurinCellsComplexCytokine SignalingFundingGenesGenetic TranscriptionGrantIKKepsilonIRF3 geneInterleukin-6LinkMAP Kinase GeneMAPK14 geneMeasles virus nucleoproteinMediatingMessenger RNAMolecularMutationNF-kappa BOsteoclastsPaget&aposs DiseasePathogenesisPathway interactionsPhenotypePhosphorylationPhosphotransferasesProteinsRegulationReportingResearch PersonnelRoleScaffolding ProteinSerineSignal TransductionTANK-binding kinase 1TNF geneTNFSF11 geneTRAF2 geneTranscription Factor AP-1Tumor Necrosis Factor-alphaUp-RegulationVitamin D3 Receptoractivating transcription factorcofactorcytokinefactor Chuman TNF proteinin vivoinsightnovelosteoclastogenesisp65programsprotein expressionresponsetranscription factorvirus genetics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Both viral and genetic factors have been implicated in the pathogenesis of Paget's disease (PD). However, the molecular mechanisms responsible for their effect on osteoclast (OCL) formation and activity in PD are unclear. It is our hypothesis that measles virus nucleoprotein (MVNP) mediates its effects in OCL precursors predominantly through increased NFicB signaling via activation of the two kB kinase (IKK)-related kinases IKKe (also called IKK-/) and TANK-binding kinase 1 (TBK1) and increased levels of RIP1 and TRAF2. This results in upregulation of IL-6 and a vitamin D receptor coactivator TAFM-17 and increases OCL formation. MVNP also drives multi-potential cells towards the OCL lineage through increased expression and activation of NFATd. The p62P392L mutation linked to PD enhances the effects of MVNP by further increasing NFxB signaling in response to TNF-ct and RANKL as well as increasing p38 MAPK activation in response to RANKL, TNF-alpha and 1,25-(OH)2D3. In support of this hypothesis, we recently found that MVNP expression increases RIP1, TRAF2, and p65 NFicB resulting in enhanced constitutive activation of NFicB, and increased NFicB responsivity to TNF-alpha and RANKL. We also found that MVNP increases NFATd and synergistically activates NFATcl-driven gene transcription, with either NFATd 'or RANKL, and induces IL-6 and TAFn-17. In addition, the p62p392L mutation activates NFicB and increases the sensitivity of OCL precursors to RANKL and TNF-alpha. MVNP also interacts with IKKe and TBK1 to activate NFKB but their role in PD are unknown. In this project we will: 1. Determine if MVNP activation of NFKB and induction of pagetic OCL formation results from alterations of the canonical pathway and/or utilization of an alternative pathway that involves activation of IKKepsilon/TBK1 and the effects of co-expression of MVNP and p62P392L on these pathways. 2. Determine if NFKB activation by MVNP is sufficient for induction of IL-6 or if other mechanisms are also necessary, and the effects of co-expression of p62R392L and MVNP on the molecular mechanlsm(s) identified above. 3. Determine if the synergy of MVNP with NFATd is due to modulation of NFATd activation or of a cofactor of NFATd. The studies of the molecular mechanisms responsible for MVNP and p62p392L effects on OCL formation outlined above" will provide important insight into the pathogenesis of PD and are directly linked to the cellular and in vivo studies proposed in Project 2,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GFI-1 and Osteoblast Suppression in Multiple Myeloma
-
批准号:8290562
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2010
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
GFI-1 and Osteoblast Suppression in Multiple Myeloma
-
批准号:8117780
-
项目类别:
-
资助金额:$27.76万
-
财政年份:2010
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
GFI-1 and Osteoblast Suppression in Multiple Myeloma
-
批准号:8681152
-
项目类别:
-
资助金额:$27.21万
-
财政年份:2010
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
GFI-1 and Osteoblast Suppression in Multiple Myeloma
-
批准号:7942687
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2010
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
GFI-1 and Osteoblast Suppression in Multiple Myeloma
-
批准号:8490313
-
项目类别:
-
资助金额:$26.37万
-
财政年份:2010
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
Viral and Genetic Regulation of Abnormal OCL Activity in PD
-
批准号:8123401
-
项目类别:
-
资助金额:$31.55万
-
财政年份:2008
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
Viral and Genetic Regulation of Abnormal OCL Activity in PD
-
批准号:7680931
-
项目类别:
-
资助金额:$32.58万
-
财政年份:2008
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
Viral and Genetic Regulation of Abnormal OCL Activity in PD
-
批准号:7901075
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2008
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
Viral and Genetic Regulation of Abnormal OCL Activity in PD
-
批准号:7689304
-
项目类别:
-
资助金额:$31.57万
-
财政年份:2008
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
Viral and Genetic Regulation of Abnormal OCL Activity in Paget's Disease
-
批准号:9515641
-
项目类别:
-
资助金额:$39.73万
-
财政年份:2008
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
REGULATION OF THE MURINE CALCITONIN RECEPTOR GENE
-
批准号:2681757
-
项目类别:
-
资助金额:$31.69万
-
财政年份:1998
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
REGULATION OF THE MURINE CALCITONIN RECEPTOR GENE
-
批准号:6043238
-
项目类别:
-
资助金额:$32.05万
-
财政年份:1998
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
REGULATION OF THE MURINE CALCITONIN RECEPTOR GENE
-
批准号:6375134
-
项目类别:
-
资助金额:$34.43万
-
财政年份:1998
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
REGULATION OF THE MURINE CALCITONIN RECEPTOR GENE
-
批准号:6171136
-
项目类别:
-
资助金额:$33.69万
-
财政年份:1998
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
CONTROL OF TRANSCRIPTION DURING MELC DIFFERENTIATION
-
批准号:3032318
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1986
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
CONTROL OF TRANSCRIPTION DURING MELC DIFFERENTIATION
-
批准号:3032317
-
项目类别:
-
资助金额:$2.0万
-
财政年份:1985
-
负责人:DEBORAH Lynn GALSON
-
依托单位:
海外基金